Texas Court Won't Revive $10M Award Against Fen-Phen Atty

Law360, Houston (April 9, 2013, 3:55 PM EDT) -- A Texas appeals court on Tuesday ruled for a second time that faulty testimony underpinned a jury’s verdict that resulted in awards exceeding $10 million against a Houston attorney who allegedly overcharged clients in litigation against a Pfizer Inc. unit over the diet drug fen-phen.

The Fourteenth District Court of Appeals denied a request by a 600-member client group to reconsider its February decision that testimony of a legal ethics expert in a test case against attorney George Fleming “crossed the border of admissibility."

Lillian Hardwick...
To view the full article, register now.